Tech Center 1600 • Art Units: 1600 1633
This examiner grants 56% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17605207 | COMPOSITIONS AND METHODS CHARACTERIZING METASTASIS | Final Rejection | Dana-Farber Cancer Institute, Inc. |
| 17615382 | ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF CYSTATHIONINE BETA-SYNTHASE (CBS) ENZYME FOR TREATING CBS DEFICIENCY | Non-Final OA | Cornell University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy